Lifecome Biochemistry Co Ltd Strategic Asset Allocation Index
Lifecome Biochemistry Co Ltd strategic asset allocation index. Lifecome Biochemistry Co Ltd (002868) has a Strategic Asset Allocation Index of 152.2% as of September 2023. Strategic assets (PP&E of CN¥782.66 Million plus long-term investments of CN¥-) total CN¥782.66 Million, measured against net assets of CN¥514.40 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Lifecome Biochemistry Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lifecome Biochemistry Co Ltd (2016–2021)
Strategic asset allocation index of Lifecome Biochemistry Co Ltd from 2016 to 2021. This chart shows how Lifecome Biochemistry Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 152.2%, representing strategic assets of CN¥782.66 Million against net assets of CN¥514.40 Million CNY. Check tangible net worth ratio of Lifecome Biochemistry Co Ltd to evaluate the tangible quality of the company's equity base.
Lifecome Biochemistry Co Ltd Strategic Asset Allocation Index by Year (2016–2021)
Lifecome Biochemistry Co Ltd strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Lifecome Biochemistry Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002868 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 125.7% | CN¥907.87 Million | CN¥907.87 Million | CN¥- | CN¥722.02 Million | ▲ +59.2 pp |
| 2020 | 66.5% | CN¥512.03 Million | CN¥512.03 Million | CN¥- | CN¥769.94 Million | ▲ +31.6 pp |
| 2019 | 34.9% | CN¥271.44 Million | CN¥271.44 Million | CN¥- | CN¥778.50 Million | ▲ +6.6 pp |
| 2018 | 28.3% | CN¥209.33 Million | CN¥209.33 Million | CN¥- | CN¥740.37 Million | ▼ -4.0 pp |
| 2017 | 32.2% | CN¥224.31 Million | CN¥224.31 Million | CN¥- | CN¥695.68 Million | ▼ -46.6 pp |
| 2016 | 78.9% | CN¥214.02 Million | CN¥214.02 Million | CN¥- | CN¥271.34 Million | — |